MARgenomics
GINYS-IMIM-006
Platform mainly aimed at translational research that integrates all phases of the genomic analysis process: from the initial phase of project advice, through the processing of samples, to the final analysis of data and support to the interpretation of the results.
Services
MARGenomics offers a wide range of services integrating all phases of a genomic analysis process, from the initial phase of project advice, to the final analysis of the data, the validation of the results and the expert support in the its interpretation.
Advice on experimental design
DNA and / or RNA extraction in different types of samples (whole blood, frozen or paraffined tissue, etc.)
DNA / RNA quality analysis (Quantification and Integrity)
- Quantification of DNA or RNA by fluorimetry and / or spectrophotometry
- DNA integrity analysis with agarose gels and / or Bioanalyzer
- RNA Integrity Analysis by Bioanalyzer
Real-time quantitative PCR (qPCR)
Microarrays
- Expression
Genomics
Next Generation sequencing (Library preparation and processing on appropriate platforms)
- Whole Genome sequencing
- Exome sequencing
- RNA sequencing
- Small RNA sequencing
- Panel sequencing
- ChIP sequencing
- Bisulfite sequencing
Data analysis
- Sequence alignment
- Variant Calling and Copy Number analysis from genomic data
- Identification of differentially expressed genes, alternative splicing and fusion genes in transcriptomic data
- Study of smallRNAs through microtranscriptome analysis.
- Identification of regions with peak protein-DNA interaction in chromatin immunoprecipitation sequencing experiments (ChIP-seq)
- Identification of positions or regions of methylated DNA in methyloma data
- Integration of data from different omic platforms using specific methodology
- Microarray analysis
- QPCR analysis
Staff
Publications
Lamin B1 mapping reveals the existence of dynamic and functional euchromatin lamin B1 domains
Nature Communications volume 9, Article number: 3420 (2018)
Nature Communications volume 9, Article number: 3420 (2018)
Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients
Genes Chromosomes Cancer . 2019 Mar;58(3):164-174. doi: 10.1002/gcc.22712. Epub 2019 Jan 7
Genes Chromosomes Cancer . 2019 Mar;58(3):164-174. doi: 10.1002/gcc.22712. Epub 2019 Jan 7
Expression profiling of microRNAs in human bone tissue from postmenopausal women
Hum Cell . 2018 Jan;31(1):33-41. doi: 10.1007/s13577-017-0181-y. Epub 2017 Sep 20.
Hum Cell . 2018 Jan;31(1):33-41. doi: 10.1007/s13577-017-0181-y. Epub 2017 Sep 20.
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach
Hematol Oncol . 2017 Dec;35(4):778-788. doi: 10.1002/hon.2304.
Hematol Oncol . 2017 Dec;35(4):778-788. doi: 10.1002/hon.2304.
FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
Hum Pathol . 2017 Apr;62:222-231.
Hum Pathol . 2017 Apr;62:222-231.